Precision Biomonitoring Receives Funding to Manufacture TripleLock™ SARS CoV-2 Go-Strips
Innovative Efforts Receive Funding from NGen In Response to Canadian Supply Development Support
GUELPH, ON and MISSISSAUGA, ON, June 2, 2020 /CNW/ - Precision Biomonitoring, an industry leader in point-of-need molecular detection tools, has announced that is has received approval and funding from Next Generation Manufacturing Canada (NGen) to support manufacturing needs for the production of its TripleLockTM SARS-CoV-2 Go-Strips.
Precision Biomonitoring has secured this funding because of its ongoing efforts to contribute to the development of a Canadian supply of testing kits in response to the COVID-19 pandemic. Precision Biomonitoring is grateful to NGen for its support and is encouraged by its dedication to companies across Canada working to develop resources and tools necessary to protect public health.
The funding will enable Precision Biomonitoring to work directly with Canadian manufacturers to rapidly increase production of its SARS-CoV-2 Go-Strips, which will not only support Precision Biomonitoring, but also other Canadian biotech companies working to support the accessibility of molecular testing amidst COVID-19 and into the future.
Leveraging the manufacturing capabilities of Canadian manufacturers, Precision Biomonitoring anticipates a production rate capacity of 10,000 units per day or greater. Increased testing capacity will help provide critical testing access and capacity in communities to re-open Canadian economy by helping to create virus-free zones in the workplace to ensure safety of the workers and sustainable operations.
"Developing Canadian manufacturing is not only promising for our response efforts for COVID-19, but also provides a strong foundation as we look to expand into the growing mobile DNA applications market," says Thomas. "This includes manufacturing our existing 35 tests for other organisms, helping to establish local sources of supply that Canadians can rely on."
Precision Biomonitoring's efforts alongside NGen is an addition to the collaborative relationships Precision Biomonitoring has developed with other Canadian companies and institutions in response to COVID-19, including Canadian Food Inspection Agency, Shared Value Solutions, The Research Institute of St. Joe's (Hamilton), Sunnybrook Health Science Centre and the Canadian National Microbiology Lab.
"Advancing Canadian manufacturing enables us to leverage local capabilities to mitigate manufacturing challenges," says John Laughlin, CTO at NGen. "We are proud to help drive these efforts that will position Canada as a world leader in manufacturing point-of-need DNA surveillance and detection tools."
About Precision Biomonitoring
Founded in 2016 by a team of scientists from the University of Guelph's Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ onsite eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organizations that need onsite surveillance and rapid identification of any organism in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry. Our vision is a world where we can identify any organism on the spot, in an instant, anywhere on the planet.
NGen is the industry-led community behind Canada's most transformative advanced manufacturing projects. NGen members come from every part of the country and cut across Canada's manufacturing, technology, advanced research, and start-ups sectors. NGen is an objective facilitator of connections and collaboration among its members, identifying opportunities, building capabilities, and supporting advanced manufacturing decisions. NGen's industry collaborations bring together talent, opportunity, funding, and business know-how to reduce risk and help business leaders make better choices. NGen is Canada's Supercluster for Advanced Manufacturing, securing funding from public and private sources, including $230 million in matching dollars from the federal government's Innovation Superclusters Initiative, to support greater private sector investment in advanced manufacturing projects. NGen seeks to add $13.5 billion dollars and 13,500 new jobs to the economy over the next 10 years by growing world-leading advanced manufacturing capabilities in Canada.
SOURCE Precision Biomonitoring